Pregnancy-associated plasma protein-A expression in human breast cancer
Growth Hormone & IGF Research · 2014-12 · 24 (6) · 264-267
DOI: 10.1016/j.ghir.2014.10.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Growth Hormone & IGF Research, 2014-12. Verfasst von Aaron S Mansfield und 6 weiteren Autor:innen. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
OBJECTIVE: Pregnancy-associated plasma protein-A (PAPP-A) is a zinc metalloproteinase in the insulin-like growth factor system that is expressed by tissues outside of pregnancy and involved in normal and dysregulated growth. PAPP-A has been implicated in several cancers. However, studies of PAPP-A expression in breast cancer are limited. In this study, we assessed PAPP-A expression in different subtypes of human malignant breast cancer. Design Formalin-fixed paraffin-embedded tumor samples from 46 female patients with invasive breast cancer were divided into five defined groups [using markers for HER2, estrogen receptor, progesterone receptor, proliferation] that roughly correlate with molecularly defined subtypes (luminal A, luminal B, luminal/HER2 +, HER2 +, triple negative). These samples were analyzed for PAPP-A expression by immunohistochemistry. RESULTS: PAPP-A staining in tumor tissue was detected in 45 of 46 specimens. There were significantly greater extent and intensity of PAPP-A expression in luminal B specimens with high proliferation index than luminal A specimens (P = 0.01). However, there were no differences between specimens positive or negative for HER2 (P = 0.14) or positive and negative for estrogen receptor (P = 0.31). CONCLUSION: PAPP-A was detected in almost all breast cancer specimens and a more intense and greater extent of its expression was associated with luminal B specimens compared to luminal A specimens. The role of PAPP-A in breast cancer prognosis, and possibly therapeutics, warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- National Institutes of Health
Zitieren
APA
Mansfield, A. S., Visscher, D. W., Hart, S. N., Wang, C., Goetz, M. P., Oxvig, C., & Conover, C. A. (2014). Pregnancy-associated plasma protein-A expression in human breast cancer. Growth Hormone & IGF Research, 24(6), 264-267. https://doi.org/10.1016/j.ghir.2014.10.007
Vancouver
Mansfield AS, Visscher DW, Hart SN, Wang C, Goetz MP, Oxvig C, et al. Pregnancy-associated plasma protein-A expression in human breast cancer. Growth Hormone & IGF Research. 2014;24(6):264-267. doi:10.1016/j.ghir.2014.10.007
BibTeX
@article{Mansfield2014,
author = {Mansfield, Aaron S and Visscher, Daniel W and Hart, Steven N and Wang, Chen and Goetz, Matthew P and Oxvig, Claus and Conover, Cheryl A},
title = {Pregnancy-associated plasma protein-A expression in human breast cancer},
journal = {Growth Hormone & IGF Research},
year = {2014},
volume = {24},
number = {6},
pages = {264--267},
doi = {10.1016/j.ghir.2014.10.007}
}
EUVIMED